Bank of America Reports Credit Card Delinquency, Net Charge-Off Rates for November
SA Asks: Is the Fed More Focused on Inflation or Jobs?
Another Week, Another Index Record | Lkive Stock
Express News | Bank of America Corp - Credit Card Delinquency Rate Was 1.51% at November End - SEC Filing
Morgan Stanley Maintains Bank of America(BAC.US) With Hold Rating, Maintains Target Price $55
Bank of America Securities: Maintains the "Buy" rating for SINO BIOPHARM, with the Target Price raised to 181 Hong Kong dollars.
Bank of America Securities released a research report stating that based on SINO BIOPHARM's (01177) latest Company Business Data, the revenue forecasts for 2024 to 2026 have been slightly adjusted upward by 0.1%, 0.2%, and 0.2%, to 29.052 billion, 31.816 billion, and 34.722 billion yuan respectively. This year's earnings per share forecast has also been raised from 0.11 yuan to 0.20 yuan. Considering its strong sales performance and good progress in product pipeline development, Bank of America has raised the Target Price for SINO BIOPHARM from 3.8 HKD to 4 HKD, reiterating a 'Buy' rating.
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
RandomTrader_ : Oil prices has been going down which means shipping will also take a hit which it currently is. Setting aside the high dividend %, what is a good motive to buy more of this stock?